Advertisement

Topics

Series A round brings $15mm to Vivace Therapeutics

15:40 EDT 30 Jun 2017 | Elsevier Business Intelligence

Vivace Therapeutics Inc. raised $15mm through a Series A round from founding investors Canaan Ventures and WuXi Healthcare Ve...

Original Article: Series A round brings $15mm to Vivace Therapeutics

NEXT ARTICLE

More From BioPortfolio on "Series A round brings $15mm to Vivace Therapeutics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...